Results 181 to 190 of about 23,676 (191)

Pyrrolo[2,3-]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation

European Journal of Medicinal Chemistry, 2020
Naresh Gunaganti, Naga Rajiv Lakkaniga, Hong-Yu Li   +2 more
exaly  

Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase

ACS Medicinal Chemistry Letters, 2020
Bohdan Waszkowycz, Daniel Burschowsky, Chitra Seewooruthun   +2 more
exaly  

Identification of RET Kinase Inhibitors as Potential New Treatment for Sporadic and Inherited Thyroid Cancer

Journal of Chemotherapy, 2004
F Carlomagno
exaly  

The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors

Bioorganic and Medicinal Chemistry Letters, 2007
Michael Skinner, Lisa Shewchuk
exaly  

Synthesis, structure–activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors

Bioorganic and Medicinal Chemistry, 2010
Carlo Gambacorti-Passerini, Luca Mologni, Alfonso Zambon   +2 more
exaly  

Synthesis and structure–activity relationship study of pyrazolo[3,4-]pyrimidines as tyrosine kinase RET inhibitors

Bioorganic and Medicinal Chemistry Letters, 2017
Zilan Song, Ao Zhang, Hongchun Liu
exaly  

Design, synthesis and evaluation of ()-1-(4-(2-(1H-pyrazol-5-yl)vinyl)phenyl) derivatives as next generation selective RET inhibitors overcoming RET solvent front mutations (G810C/R)

European Journal of Medicinal Chemistry
Qian Cai, Lijie Peng
exaly  

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making.

Ca-A Cancer Journal for Clinicians
Lucas Cunha, Ana O Hoff, Rachel Riera
exaly  

Design and synthesis of indol-2-one derivatives as potential RET inhibitors

Bioorganic and Medicinal Chemistry Letters
Yaxia Yuan, Xiabin Chen, Yuanhong Xu
exaly  

Recent Advances in the Development of RET Inhibitors

Letters in Drug Design and Discovery
exaly